Literature DB >> 16182758

Quality-of-life assessment before and after liver transplantation.

M Sainz-Barriga1, U Baccarani, L Scudeller, A Risaliti, P L Toniutto, M G Costa, M Ballestrieri, G L Adani, D Lorenzin, V Bresadola, G Ramacciatto, F Bresadola.   

Abstract

BACKGROUND: Quality-of-life (QoL) assessment includes health status, disability, psychological wellness, and social performance. We sought to evaluate the effect of liver transplantation (OLT) on the QoL of patients awaiting the procedure and its variations up to 8 years afterwards.
METHODS: LEIPAD-perceived QoL and BSI-psychological distress tests were used. Patients were divided in four groups (waiting list patients, 1 to 2 years after LT, 3 to 4 years after LT, 5 to 8 years after LT). Patients were also evaluated for type and severity of liver disease.
RESULTS: We evaluated 126 patients, 71% male, 29% female, median age 60.7 years (range 40 to 76 years), median follow-up 4 years (range 1 to 8). The patients on the waiting list scored worse both in global stress index (GSI) and total LEIPAD scores than transplanted patients. Upon univariate linear regression analysis, the only dimension associated with time groups was LEIPAD--physical functioning, showing a progressive improvement of perceived physical status with time from transplant. Severity of liver disease showed a protective effect, probably reflecting a better control of stressful events from patients transplanted at advanced stages of liver disease. Protective effects were found for male sex, retired, cohabitant patients, and the degree of education. Housewife and widow patients showed negative associations with BSI and LEIPAD dimensions. No independent predictors of QoL were found in this study.
CONCLUSIONS: OLT improves most, but not all, QoL and psychological distress domains.

Entities:  

Mesh:

Year:  2005        PMID: 16182758     DOI: 10.1016/j.transproceed.2005.06.045

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  9 in total

1.  The power of the liver transplant waiting list: a case presentation.

Authors:  Lissi Hansen; Yi Yan; Susan J Rosenkranz
Journal:  Am J Crit Care       Date:  2014-11       Impact factor: 2.228

2.  Cross-cultural evaluation of the French version of the LEIPAD, a health-related quality of life instrument for use in the elderly living at home.

Authors:  I Jalenques; C Auclair; J Roblin; D Morand; R Tourtauchaux; R May; E Vaille-Perret; J Watts; L Gerbaud; D De Leo
Journal:  Qual Life Res       Date:  2012-04-03       Impact factor: 4.147

3.  [Liver transplantation. From innovation to routine].

Authors:  M W Büchler
Journal:  Chirurg       Date:  2008-02       Impact factor: 0.955

Review 4.  Quality of life, risk assessment, and safety research in liver transplantation: new frontiers in health services and outcomes research.

Authors:  Zeeshan Butt; Neehar D Parikh; Anton I Skaro; Daniela Ladner; David Cella
Journal:  Curr Opin Organ Transplant       Date:  2012-06       Impact factor: 2.640

Review 5.  Key psychosocial challenges in vascularized composite allotransplantation.

Authors:  Martin Kumnig; Sheila G Jowsey-Gregoire
Journal:  World J Transplant       Date:  2016-03-24

6.  Six Minute Walk Test to assess functional capacity in chronic liver disease patients.

Authors:  Hatem F Alameri; Faisal M Sanai; Manal Al Dukhayil; Nahla A Azzam; Khalid A Al-Swat; Ahmad S Hersi; Ayman A Abdo
Journal:  World J Gastroenterol       Date:  2007-08-07       Impact factor: 5.742

7.  Liver transplantation for hepatitis C and alcoholic liver disease.

Authors:  Marco Carbone; James Neuberger
Journal:  J Transplant       Date:  2010-12-15

8.  Validation of the French version of the LEIPAD in community-dwelling people aged 80 years and above.

Authors:  Isabelle Jalenques; Candy Guiguet-Auclair; Laurent Gerbaud; Chloé Rachez; Fabien Rondepierre
Journal:  PLoS One       Date:  2019-03-19       Impact factor: 3.240

9.  Factors Affecting Exercise Test Performance in Patients After Liver Transplantation.

Authors:  Katarzyna Kotarska; Ewa Wunsch; Lukasz Jodko; Joanna Raszeja-Wyszomirska; Izabela Bania; Malgorzata Lawniczak; Dimitrios Bogdanos; Zdzislawa Kornacewicz-Jach; Piotr Milkiewicz
Journal:  Hepat Mon       Date:  2016-03-21       Impact factor: 0.660

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.